摘要
目的探讨头孢哌酮舒巴坦治疗单纯性淋病的最佳剂量。方法以2008年10月～2011年2月单纯性淋病患者60例为研究对象。随机将患者分为试验组和对照组各30例。对照组给予头孢哌酮舒巴坦1.5 g/d,试验组给予头胞哌酮舒巴坦2.25 g/d,观察对比两组患者的疗效和不良反应。结果试验组患者治疗3 d后疗效优于对照组,差异有统计学意义(P<0.05);两组患者不良反应比较差异无统计学意义(P>0.05)。结论采用头孢哌酮舒巴坦治疗单纯性淋病的效果较好,不良反应少,2.25 g/d剂量最佳。
Objective To investigate the optimal dose of cefperazone-sulbactam in the treatment of uncomplicated gonorrhea. Methods 60 cases of hospital patients with uncomplicated gonorrhea from October 2008 to February 2011 were chosen. Patients were randomly divided into two groups, control group were given cefperazone-sulbactam daily 1.5 g, experimental group was given the first cell risperidone the sulbactam 2.25 g daily, the efficacy and adverse reactions were compared between the two groups. Results The efficacy of the experimental group after 3 days treatment was better than the control group, the difference was statistically significant P 〈0.05; the rate of adverse reactions in two groups was no significant difference （P〉 0.05）. Conclusion The cefperazone-sulbactam is better, fewer adverse reactions in treatment of uncomplicated gonorrhea, 2.25g/d dose is the best.
出处
《当代医学》
2013年第4期156-157,共2页
Contemporary Medicine
关键词
头胞哌酮舒巴坦
淋病
单纯性淋病
剂量
Cefperazone-sulbactam
Gonorrhea
Uncomplicated gonorrhea
Dose
